EPR25-117: Cardiovascular Events in Patients Diagnosed With Light Chain Amyloidosis in the USA: A Real-World Analysis Utilizing Electronic Health Records
"EPR25-117: Cardiovascular Events in Patients Diagnosed With Light Chain Amyloidosis in the USA: A Real-World Analysis Utilizing Electronic Health Records" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- A Gupta (ORCID: https://orcid.org/0000-0001-8485-2646)
- Richa Manwani
- Jeffrey C. Thompson (ORCID: https://orcid.org/0000-0001-5734-0004)
- P.A. Laires (ORCID: https://orcid.org/0000-0002-1930-7913)
- Brendon Staruk
- Jennifer Evans (ORCID: https://orcid.org/0000-0002-6137-2030)
- Abhishek Gaur (ORCID: https://orcid.org/0000-0001-6133-255X)
- Shona Fang (ORCID: https://orcid.org/0009-0008-7019-5647)
Institutions
- AstraZeneca (United Kingdom) (GB)
- Optum (United States) (US)
- AstraZeneca (Spain) (ES)
- AstraZeneca (United States) (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7328
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00